Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma

Conclusion: Our study provides a novel two-prognostic gene signature—based on MMRGs—that accurately predicted the survival of patients with PAAD and could be used for mitochondrial energy metabolism–related therapies in the future.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research